Koers SciClone Pharmaceuticals (Holdings) Limited
Aandelen
6600
KYG4271B1023
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,04 HKD | +14,25% | 0,00% | +15,23% |
Omzet 2023 | 3,16 mld. 437 mln. 3,42 mld. 405 mln. | Omzet 2024 * | 3,53 mld. 489 mln. 3,83 mld. 454 mln. | Marktkapitalisatie | 9 mld. 1,25 mld. 9,75 mld. 1,16 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | 1,12 mld. 155 mln. 1,22 mld. 144 mln. | Nettowinst (verlies) 2024 * | 1,07 mld. 148 mln. 1,16 mld. 138 mln. | EV/omzet 2023 | 2,44 x |
Nettoliquiditeiten 2023 * | 1,3 mld. 180 mln. 1,41 mld. 167 mln. | Nettoliquiditeiten 2024 * | 2 mld. 278 mln. 2,17 mld. 257 mln. | EV/omzet 2024 * | 1,98 x |
K/w-verhouding 2023 |
7,36
x | K/w-verhouding 2024 * |
8,76
x | Werknemers | 1.000 |
Dividendrendement 2023 * |
2,54% | Dividendrendement 2024 * |
1,49% | Vrij verhandelbaar | 52,47% |
1 dag | +14,25% | ||
Lopende maand | +23,20% | ||
1 maand | +22,44% | ||
3 maanden | +16,91% | ||
6 maanden | +62,02% | ||
Lopend jaar | +15,23% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hong Zhao
CEO | Chief Executive Officer | 60 | 01-06-20 |
Rong Rong Pan
DFI | Director of Finance/CFO | 46 | - |
Mao Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 13-06-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Vasella
BRD | Director/Board Member | 70 | 01-06-20 |
Hong Zhao
CEO | Chief Executive Officer | 60 | 01-06-20 |
Zhen Fu Li
CHM | Chairman | 59 | 01-06-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.52% | 4 M€ | -27,92% | ||
0.05% | 12 M€ | -16,71% | - |
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,23% | 1,25 mld. | |
+0,44% | 90,78 mld. | |
+9,61% | 43,96 mld. | |
-16,67% | 31,34 mld. | |
+44,99% | 23,45 mld. | |
-9,42% | 16,48 mld. | |
-25,92% | 15,03 mld. | |
-9,27% | 12,79 mld. | |
-7,57% | 12,19 mld. | |
+0,07% | 8,5 mld. |